Document Detail


Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment.
MedLine Citation:
PMID:  16953393     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim was to analyze the clinical outcome of a group of 51 patients diagnosed with systemic amyloidosis associated with rheumatoid arthritis who received hemodialysis (HD) as renal replacement therapy. We monitored the clinical course of the disease and factors that could influence survival. Determination of the onset of the underlying disorder was made retrospectively by reviewing the patient's chart when a diagnosis of amyloid was confirmed. During a 96.9 person-year follow-up, 42 patients died. Survival of these 51 patients from the initiation of HD at 251 days was 50%. Poor prognosis in amyloid patients was mainly due to a large number of sudden deaths immediately following HD therapy. Out of 51 patients 21 needed unplanned initiation of HD. The unplanned initiation was significantly associated with poor survival. Seventy-five percentile of creatinine clearance (Ccr) was 9.7 ml/min, and 75% of these patients who initiated HD had highly impaired renal functional states. These data indicated that amyloidotic patients with HD showed a high mortality rate; therefore, planned initiation of HD was highly recommended to improve the patient's survival. Particular attention was given to the Ccr levels, because the levels of serum creatinine may not be a useful marker for some patients with amyloidosis.
Authors:
Takeshi Kuroda; Naohito Tanabe; Hiroe Sato; Jyunya Ajiro; Yoko Wada; Syuichi Murakami; Hisashi Hasegawa; Minoru Sakatsume; Masaaki Nakano; Fumitake Gejyo
Related Documents :
9493983 - Hirschsprung-associated congenital anomalies.
10770973 - Effect of uremia and dialysis modality on mononuclear cell apoptosis.
18805573 - Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comp...
Publication Detail:
Type:  Journal Article     Date:  2006-09-05
Journal Detail:
Title:  Rheumatology international     Volume:  26     ISSN:  0172-8172     ISO Abbreviation:  Rheumatol. Int.     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-09-25     Completed Date:  2007-02-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8206885     Medline TA:  Rheumatol Int     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1147-53     Citation Subset:  IM    
Affiliation:
Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-Dori, Niigata City 951-8510, Japan. kurodat@med.niigata-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amyloidosis / complications*
Arthritis, Rheumatoid / etiology,  mortality*,  therapy*
Female
Humans
Male
Middle Aged
Renal Dialysis*
Survival Rate
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Plasma and cerebrospinal fluid pharmacokinetics of nelarabine in nonhuman primates.
Next Document:  Effects of glucosamine administration on patients with rheumatoid arthritis.